The EU's generic drug approval system is complex, with four pathways, national variations, and major 2025 reforms. Learn how regulatory changes are speeding up access, cutting delays, and reshaping market competition across Europe.
The EU's generic drug approval system is complex, with four pathways, national variations, and major 2025 reforms. Learn how regulatory changes are speeding up access, cutting delays, and reshaping market competition across Europe.
